Codexis, Inc. (CDXS) is a publicly traded Healthcare sector company. As of November 12, 2026, CDXS trades at $1.00 with a market cap of $106.92M and a P/E ratio of -4.20. CDXS moved -2.66% today. Year to date, CDXS is -41.29%; over the trailing twelve months it is -50.41%. Its 52-week range spans $0.91 to $3.87. Analyst consensus is strong buy with an average price target of $6.50. Rallies surfaces CDXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CDXS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $106.92M |
| P/E Ratio | -4.20 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.87 |
| 52-Week Low | $0.91 |
| Volume | 915.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $77.68M |
| Net Income | $-30.72M |
| Gross Margin | 87.02% |
5 analysts cover CDXS: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.50.